• The Best Choice in Healthcare, Period

    By Matthew Frankel - March 9, 2013 | Tickers: JNJ, NVS, PFE

    Everyone should have some exposure to healthcare/biotechnology in their long-term portfolio.  There are many exciting choices, ranging from big pharma to highly speculative biotech companies, so which is right for you?  Believe it or not, my favorite for long-term growth and income is Johnson & Johnson (NYSE: JNJ), which has an undeserved reputation for being a boring investment.

    About Johnson & Johnson

    Johnson & Johnson is one of the largest healthcare companies more »

  • Pfizer Earnings: Will The Biggest Keep Getting Bigger?

    By Matthew Frankel - January 28, 2013 | Tickers: MRK, NVS, PFE

    Pfizer (NYSE: PFE) has done well for its shareholders over the past several years, although it is still trading toward the lower end of its 10-year range.  Investors in the world’s largest pharmaceutical company will want to see signs of growth ahead when Pfizer reports earnings next Tuesday. 


    <img src="/media/images/user_14267/pfe-chart_large.png" />


    Pfizer has what is possibly the most diverse drug portfolio in the sector, with products including Lipitor, Novarsc, Lyrica, Prevnar, Enbrel more »

  • Obamacare: Three Firms That Will Do Well From the Affordable Care Act

    By Nate Wooley - January 24, 2013 | Tickers: HCA, MD, THC | Editor's Choice

    The Patient Protection and Affordable Care Act, or Obamacare, is beginning to be felt in the healthcare community. Health providers and insurance companies are starting to deal with the changes in our health system. How can you take advantage of it?

    I'm not here to judge Obamacare. That's not my role. My job is to look into the future and provide some advice about how to invest your more »

  • Three Drug Manufacturers Offering The Best Value Today

    By Cagdas Ozcan - January 23, 2013 | Tickers: ABT, JNJ, MRK

    There are various industries which have provided very safe returns throughout history, and drug manufacturing is certainly one of them. It is one of the rare industries providing sleep-at-night investments. There will never be a peak for producing new drugs because illnesses will be on the face of the earth as long as human kind exists. New drugs with the least side effects and higher efficacy are always favored, so more »

  • Johnson and Johnson's Earnings Should Confirm What a Great Company it Is

    By Matthew Frankel - January 15, 2013 | Tickers: JNJ, PFE

    Johnson and Johnson (NYSE: JNJ) is one of the largest and most diverse health care companies in the world, with a market cap of just over $200 billion.  The company is generally looked at as a rock-solid investment that pays a nice dividend of around 3.4%.  With the company set to report earnings on Jan. 22, investors will want to hear several things, especially in regards to recent acquisition more »

  • 3 Risks This Pharmacy Retailer Should Worry About

    By William Bias - January 11, 2013 | Tickers: CVS, ESRX, WAG

    Every equity investment comes with its own set of risks. Evaluating those risks is an important step in determining the worthiness of a potential investment. Looking at pharmacy retailer Walgreen’s (NYSE: WAG)  2012 form 10K three risks stand out as especially relevant in determining Walgreen’s future as an investment.

  • Are These Stocks Worth "Howling" Over?

    By David Mercer - January 9, 2013 | Tickers: MWIV, PETS, WOOF | Editor's Choice

    Anyone that knows me personally knows I love animals and everything four-legged. In recent years, a number of pet-focused companies became prominent in the financial markets, we'll examine three (3) of them. The first is PetMed Express (NASDAQ: PETS). As its name suggests, PETS or 1-800 Pet Meds, as advertised on television, caters to pet owners, more specifically as a mail order pet pharmacy. This includes pet medications as more »

  • 10 Stocks for 2013: #1 Intuitive Surgical

    By Dave Zaegel - January 7, 2013 | Tickers: ABT, ABBV, ISRG, UNH, UAM | Editor's Choice

    It's time again to look ahead to the next year.  We put together a 10 Stock list for 2012 at Fastball Financial and achieved so-so results (a gain for that group of stocks, but they still did not outperform the S&P 500 as a whole...we'll put out a separate review on that soon).  Looking ahead to 2013, we see a continued strengthening in the economy, assuming more »

  • Arena's Short Interest Continues To Be Held At Bay While Fundamentals Play Out

    By Joseph Dedvukaj - December 17, 2012 | Tickers: ARNA

    Arena (NASDAQ: ARNA) short interest has grown to a peak of 61,748,793 shares on Nov 15 2012. Followed by the most recent decline to 56,263,870. Some smart shorts exited their positions. A short squeeze can be deliberately induced by a hedge fund or institution at any moment. We savvy investors closely monitor the daily available to short box to determine whether or not shorts are having more »

  • A Fast Growing HealthCare Stock for Your Porfolio

    By Anh HOANG - December 6, 2012 | Tickers: AET, NVS, QCOR, SNY

    Questcor Pharmaceuticals (NASDAQ: QCOR), the darling of the stock market in 2010 and 2011 has plunged significantly in the middle of 2012. Year-to-date, Questcor has lost more than 35% of its market value, to the current share price of $25.66 per share. Interestingly, the insiders have been accumulating its shares since the beginning of November this year at the average price of $24 per share, after the series of more »

  • How to Choose a Big Pharma Stock

    By Matthew Frankel - November 12, 2012 | Tickers: ABT, AZN, JNJ, MRK, PFE

    While trying to create the perfectly diversified portfolio, any investor should allocate a portion of their investments to the healthcare field.  Of particular interest, especially for long-term investors, are the big pharmaceutical companies.  They tend to have strong growth rates, which not only leads to an increased share price over time, but a high dividend that increases as well. 

    When trying to choose which particular company or companies to more »

  • Eldercare Robots

    By Frank Tobe - November 3, 2012

    Games, sensors and robots are among the tools beginning to come to market to help aging people live in their homes as long as possible.

    By Frank Tobe, Editor and Publisher, The Robot Report


    <img border="0" height="155" src="" width="200" />

    Source: BusinessWeek Magazine

    In December, 2003, BusinessWeek Magazine interviewed Joseph Engelberger, the robotics pioneer. The article was entitled "How Robots Lost Their Way." Included in the article was a plea for money to build an eldercare more »

  • A Healthcare Provider Warren Buffett is Excited About

    By Anh HOANG - October 16, 2012 | Tickers: BRK-A, DVA, FMS, HGR

    Recently, the most successful investor in the world, Warren Buffett has topped off his position in DaVita (NYSE: DVA) for an average price of $107.80. Now his company, Berkshire Hathaway (NYSE: BRK-A) owns more than 9.6 million shares, equivalent to 10.8% of the company. Berkshire first bought 2.7 million shares of DaVita at the end of 2011 for around $71 per share. Since then, DaVita has more »

  • NuVasive: Waiting For The Sun to Shine, Again

    By Gargi Banerjee - October 8, 2012 | Tickers: NUVA

    For a small cap spinal-orthopedic device maker NuVasive (NASDAQ: NUVA), the journey from being touted as the "perfect stock" by analysts to being written off by the same people must have come as a hard blow. The disappointing third quarter earnings announced last Wednesday has not only invited concern among shareholders, but also cast a shadow on the company’s future prospects.

    Not Far from Target but Still a Miss more »

  • Obamacare--How To Profit

    By Sharmistha Banerjee - October 3, 2012 | Tickers: HCA, THC, UHS

    Hospital stocks have performed well amid expectations that Obamacare will survive as his chances of re-election look better. Hospitals will see more patients with health insurance which increases the pool of customers by 10% in the coming year. This massive health insurance coverage expansion is about to unfold in the U.S, beginning  in 2014, and is expected to benefit providers uniquely since the coverage expansion will yield fewer uninsured more »

  • Soaring Penny Stocks

    By Sharmistha Banerjee - October 2, 2012 | Tickers: FOLD, CPRX, TGX

    I am particularly smitten with health care penny stocks. Investing in so-called penny stocks is certainly attractive. But rampant speculation followed by investment in unregulated market can lead the portfolio to go haywire. Therefore extensive research and understanding the business is of real importance rather than being taken for a ride. Penny stocks have a solid reputation for being a risky investment; however, if the potential rewards excite you, then more »

  • Healthcare is Here to Stay

    By Sharmistha Banerjee - September 21, 2012 | Tickers: AET, KRFT, MOH, GTS, UNH, UAM

    According to Morgan Stanley; Healthcare is an attractive sector in the U.S and rates the reasons as achievable earnings estimates, rich cash flows, and modest valuations.

    Dow average dumps Kraft Foods (NASDAQ: KRFT) for UnitedHealth Group (NYSE: UNH). The second oldest most closely watched U.S. benchmark said it was dropping Kraft because it is about to become a much smaller company after spinning off its North American grocery more »

  • Pfizer Prodigy Spotlights $22B Animal Health Market

    By Gerelyn Terzo - August 14, 2012 | Tickers: LLY, MRK, PFE

    I've always been taught that much can be derived from the meaning of a name. If this adage is true, than Pfizer (NYSE: PFE) subsidiary New York-based Zoetis Inc., which has filed its IPO registration statement with the US Securities and Exchange Commission (SEC), has a bright future ahead in the publicly traded markets. The root word for Zoetis is zo, which of course is part of the more more »

  • Three Healthcare Stocks Top My Watch List

    By Matthew DiLallo - June 8, 2012 | Tickers: ATHN, CHSI.DL, CTRX, ISRG, MAKO

    Having just added a health care REIT to my paper trading portfolio that I call the “No Drip, No Mess” Portfolio I’m looking to add a few industry related companies to my watch list.  Today I am adding three companies that work to improve the lives of both patients and doctors while saving money in the process.  I’ll look to add one of these companies to the portfolio more »

  • A Healthy Way to Invest in Real Estate

    By Matthew DiLallo - June 7, 2012 | Tickers: CYH, HCN, HLS, MPW, VTR

    If you’ve read any of my previous articles you know that dividends are very important to my investing philosophy.  One of the best places to find the type of dividends I like is found in a Real Estate Investment Trust (REIT).  I’ll be looking to allocate at least 10% of my “No Drip, No Mess” Portfolio to REITS as this steady income will provide the funds I’ll more »

  • Page 1 of 3